Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Onkos Surgical reported engagement with 303 surgeons and other clinicians in the states MedaRep covers, worth $201K in consulting, speaking, meals and travel for its device products, the most in Illinois ($70K to 3). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Illinois ($70K, 3 engaged), Ohio ($29K, 17 engaged), California ($23K, 23 engaged), Pennsylvania ($21K, 12 engaged), Virginia ($11K, 3 engaged).
In the last ten years FDA made 7 decisions for Onkos Surgical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2021 (3). The latest was on 2023-01-30.
| ELEOS Limb Salvage System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Onkos Surgical.